Your browser doesn't support javascript.
loading
Can thymidine phosphorylase be a predictive marker for gemcitabine and doxifluridine combination chemotherapy in cholangiocarcinoma?: case series.
Kang, Myoung Hee; Lee, Won Sup; Go, Se-Il; Kim, Moon Jin; Lee, Un Seok; Choi, Hye Jung; Kim, Dong Chul; Lee, Jeong-Hee; Kim, Hoon-Gu; Bae, Kyung Soo; Cho, Jae Min.
Affiliation
  • Kang MH; From the Department of Internal Medicine (MHK, WSL, S-IG, MJK, USL, HJC, H-GK); Department of Pathology (DCK, J-HL); and Department of Surgery, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, South Korea (KSB, JMC).
Medicine (Baltimore) ; 93(28): e305, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25526478
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymidine Phosphorylase / Bile Duct Neoplasms / Bile Ducts, Intrahepatic / Floxuridine / Cholangiocarcinoma / Deoxycytidine Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymidine Phosphorylase / Bile Duct Neoplasms / Bile Ducts, Intrahepatic / Floxuridine / Cholangiocarcinoma / Deoxycytidine Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2014 Document type: Article Country of publication: United States